Diabetes complications and extracellular vesicle therapy

Area of Science:

• Biomedical Science
• Regenerative Medicine
• Endocrinology

Background:

• Diabetes mellitus is a chronic condition with severe microvascular and macrovascular complications.
• Current treatments for diabetic complications focus on symptom management and glycemic control.
• Extracellular vesicles (EVs) are emerging as a novel cell-free therapeutic strategy for diabetes.

Purpose of the Study:

• To review the current understanding of diabetic complications.
• To summarize recent advances in the application of EVs for treating diabetes-related issues.
• To provide recommendations for future research directions in EV-based therapies for diabetes.

Main Methods:

• Literature review of existing studies on diabetic complications.
• Analysis of research on extracellular vesicle biogenesis, cargo, and therapeutic potential.
• Synthesis of current findings on EV applications in preclinical and clinical settings for diabetes.

Main Results:

• EVs contain bioactive molecules that can modulate pathological processes, promoting tissue repair.
• EVs exhibit low immunogenicity and high storage stability, comparable to cell-based therapies.
• Growing evidence supports the regenerative and immunomodulatory capabilities of EVs in diabetes models.

Conclusions:

• Extracellular vesicles represent a promising cell-free therapeutic approach for managing diabetic complications.
• Further research is needed to optimize EV production, delivery, and clinical translation for diabetes.
• EVs offer a potentially safer and more effective alternative to current treatment modalities for diabetes-related conditions.